Disruptive Technology Content Hub ARKG Offers Exposure to Advancements in Synthetic Biology By Elle Caruso FitzgeraldSeptember 15, 2022
Disruptive Technology Content Hub Shares of Signify Health Propelled by Buyout Prospects By Elle Caruso FitzgeraldSeptember 1, 2022
Disruptive Technology Content Hub Opportunities Emerge From Rapid Cost Declines in Gene Editing and Synthesis By Elle Caruso FitzgeraldAugust 26, 2022
Disruptive Technology Content Hub ARKG Holding Butterfly Network Increases 127% in Past Month By Elle Caruso FitzgeraldAugust 12, 2022
Disruptive Technology Content Hub ARKG Top Holding Signify Reported to Be Acquisition Target by CVS By Elle Caruso FitzgeraldAugust 8, 2022
Disruptive Technology Content Hub Investors Flocked to ARKK and ARKG in July as Growth Rebounded By Elle Caruso FitzgeraldAugust 5, 2022
Disruptive Technology Content Hub Shares of Verve Therapeutics Up 84% in Past Month; Get Exposure With ARKG By Elle Caruso FitzgeraldJuly 26, 2022
Disruptive Technology Content Hub Everything Advisors Need to Know About ARKG’s Q2 Performance By Elle Caruso FitzgeraldJuly 21, 2022
Disruptive Technology Content Hub ARK to Close Passive Transparency ETF, CTRU By Elle Caruso FitzgeraldJuly 20, 2022
Disruptive Technology Content Hub ARKG Increases Over 36% as Biotech’s Rebound Enters Second Month By Elle Caruso FitzgeraldJuly 13, 2022
Disruptive Technology Content Hub Small-Caps’ Comeback Advantageous for Active Managers By Elle Caruso FitzgeraldJuly 8, 2022
Disruptive Technology Content Hub ARKG Holding Accolade Up 60% in Past Month By Elle Caruso FitzgeraldJuly 7, 2022
Disruptive Technology Content Hub ARKG Leads in 1-Week Returns as Biotech Rebounds By Elle Caruso FitzgeraldJune 29, 2022
Expert Insights Chart of the Week: Advisors Remain Confident in Disruptive Innovation By Todd RosenbluthJune 23, 2022
Disruptive Technology Content Hub Get Exposure to the Genomic Revolution With ARKG By Elle Caruso FitzgeraldJune 9, 2022
Disruptive Technology Content Hub An Innovative ETF Opportunity That Taps Into Our Increased Understanding of the Human Genome By Max ChenJune 8, 2022
Disruptive Technology Content Hub Change the DNA of Your Portfolio: Growth Opportunities Through Genomics By Max ChenJune 7, 2022
Disruptive Technology Content Hub Investors Flock to ARKK; Fund Sees $658 Million in May Inflows By Elle Caruso FitzgeraldJune 3, 2022
